The Cross Just Fired at NeOnc, But Insiders Keep Getting Burned
Thomas Chen runs NeOnc and just put $140,000 into his own brain-cancer play at $3.86, his second buy in the mix alongside another insider this past month. The setup looks clean on the surface. The 8-day crossed above the 20-day two days ago, all three timeframes read Buy, and healthcare has been grinding higher for three months straight. Here's what keeps this from being a real signal: the history on this name is ugly. Past insider buys here have averaged a 20% loss at 90 days and won less than 1 in 10 times, so a CEO check and a fresh cross aren't enough to trust the entry. Watch it, don't chase it.
The Filing
| Ticker | NTHI |
| Company | NEONC TECHNOLOGIES HOLDINGS, INC. |
| Insider | Thomas Chen, CEO |
| Buy amount | $140,000 |
| Filing date | August 18, 2026 |
| Conviction | Interesting · 64/100 |
| Setup type | Momentum Ride |
Ultimate members received this analysis in real time.